Team

Leadership

Our international team of clinicians, scientists and healthcare professionals has been working on Machine Learning, Medical Imaging in Ophthalmology and Hardware Design for more than 10 years. Bringing together powerful algorithms, insights and experience to the support of eye care professionals in the analysis of medical data.

Sandro De Zanet, PhD
Co-Founder, Head of Research

Sandro De Zanet, PhD

PhD & Research engineer for image processing & Machine Learning in ophthalmology (Fundus, OCT, MRI) and TEM images.

+10 years professional working experience. Post-Doc at Computer Vision Laboratory EPFL. Experience in Stereo vision and computer vision.

Co-Founder, CEO
Co-Founder, CEO

Carlos Ciller, PhD

PhD in Medical Imaging in Ophthalmology and Machine Learning (Magnetic Resonance Imaging, Fundus, OCT).

+10 years of professional working experience in Research and Development. Ex-president of Innovation Forum Imperial College London.

Stefanos Apostolopoulos, PhD
Co-Founder, Technical Director - CTO

Stefanos Apostolopoulos, PhD

PhD in Biomedical Engineering from the Ophthalmic Technology Laboratory (OTL), UniBern.

+15 years of professional experience. Focus on OCT (hardware & software), slit-lamps, computer vision & real-time systems integration. Creator of the OpenTK library for computer graphic.

Director of Finance
VP of Finance

Christerlina Laing-Parisod, CPA

+15 years international business experiences in pharmaceutical companies, hospitals and startups, including initial public offerings (IPO), mergers and acquisitions and accounting (Swiss CO, IFRS & US GAAP) and finance. Focus in tech industry and scaling startups.

VP Commercial
VP of Strategic Marketing and Research Partnerships

Nataša Jovic, BSc-MBA

B.Sc. from the University of British Columbia and an MBA from the Segal Graduate School of Business, Simon Fraser University.

+20 years of professional working experience in Brand Development, Marketing & Commercial Development across several categories with a primary focus in Ophthalmology.

VP of Business Development

Aunia Grogan, MA

B.A. in Modern European Studies and an MA in Marketing from Kingston University.

+30 years of professional experience in commercial strategy, operational
roles, management consulting and leadership, including roles in global pharma and AI health technology startups.

Paris Hatzianastasiadis, BSc., MSc. 
VP of Sales

Paris Hatzianastasiadis, BSc., MSc. 

BSc Biology, MSc Molecular Biology from Wichita State University.25+ years of International Medical Device sales, including management and Leadership roles, developing strategies for introducing novel technologies into the market.

Board of Directors

Carlos Ciller, PhD
Chairman of BoD

Dr. Carlos Ciller, PhD

PhD in Life Sciences with a focus on machine learning and medical imaging from University of Lausanne (CHUV-CIBM) & EPFL, and the ARTORG Center from University of Bern.

During 2015-2016 he was a visiting PhD student at BioMedIA, in the Department of Computing from Imperial College London, UK. Several years of work experience as Project Manager R&D in IT and Healthcare. Former President of Innovation Forum Imperial College London, has participated in +15 peer-reviewed journal publications, patents and books.

Stefanos Apostolopoulos, PhD
Member of BoD

Dr. Stefanos Apostolopoulos, PhD

PhD in Biomedical Engineering from the Ophthalmic Technology Laboratory (OTL), UniBern.

+15 years of professional experience. Focus on OCT (hardware & software), slit-lamps, computer vision & real-time systems integration. Creator of the OpenTK library for computer graphic.

Sandro de Zanet, PhD
Member of BoD

Dr. Sandro De Zanet, PhD

PhD & Research engineer for image processing & Machine Learning in ophthalmology (Fundus, OCT, MRI) and TEM images.

+10 years professional working experience. Post-Doc at Computer Vision Laboratory EPFL. Experience in Stereo vision and computer vision.

Dr. Volker Wendel, PhD
Member of BoD

Dr. Volker Wendel, PhD

Volker Wendel, CEO of Sanoptis, founded the ophthalmology network in 2018 with support from Telemos Capital. Under his leadership, Sanoptis expanded to over 400 locations across six countries, becoming a European market leader.

In 2022, Groupe Bruxelles Lambert (GBL) became the majority shareholder. With a background in Business Administration and a PhD in Healthcare Management, Volker has built a career in healthcare, holding roles at Roland Berger, the University Hospital of Essen, AMEOS, and Artemis eye clinics, where he developed a passion for ophthalmology.

Paul Yoo
Member of Bod

Paul Yoo, O.D.

Paul Yoo, OD, is a seasoned executive in the ophthalmic and healthcare innovation sector, currently serving as Vice President of Corporate Venture Capital and Chief of Staff at Topcon Healthcare. He has held leadership roles at Equinox Ophthalmic, ClarVista Medical, Carl Zeiss Meditec, and AcuFocus, driving clinical operations, regulatory strategy, and product innovation.

His work has led to significant regulatory approvals for novel ophthalmic devices. Paul holds a Doctor of Optometry degree from the Southern California College of Optometry and a B.A. in Cellular and Molecular Biology from UC Berkeley. 

Scientific Advisors

Co-Founder & Scientific Advisor

Prof. Dr. Raphael Sznitman

Professor, Director ARTORG Center from University of Bern and Group Head at the Ophthalmic Technologies Laboratory (OTL).

Clinical Advisor

PD Dr. Dr. Marion R. Munk MD, PhD, FEBO

Head of Research at Gutblick AG. Uveitis & Medical Retina specialist.

CMO at Isarna Therapeutics. Adjunct Faculty at Northwestern University, Chicago, USA >12yrs clinical expertise in retina & clinical trials.